Daniel Pichl Net Worth & Insider Trades

Daniel Pichl - Chief People Officer, Springworks Therapeutics, Inc

As of January 27, 2023

What is Daniel Pichl's Net Worth?

The current estimated net worth of Springworks Therapeutics, Inc's Chief People Officer, Daniel Pichl, is estimated to be about $153.13K . Daniel Pichl owns about 35,203 units of Springworks Therapeutics, Inc common stock. In the last 3 years at Springworks Therapeutics, Inc, Daniel Pichl has sold an estimated value of $135.53K worth.

What is Daniel Pichl's Past Insider Trading?

Daniel Pichl's largest sale order was 858 units , worth over $26.6K on January 27, 2023. In total, Daniel Pichl has made about 8 transactions over 3 years of their time at Springworks Therapeutics, Inc. Daniel Pichl usually trades in January, with the busiest year in 2023.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Daniel Pichl's Salary in 2020?

As Chief People Officer of Springworks Therapeutics, Inc, Daniel Pichl has a total base salary of $145,833 . Daniel Pichl received compensation valued at about $2,315,128 in 2020 after becoming Chief People Officer. The vast majority of their compensation came in the form of option awards of $2,095,305 , other earnings, plans or compensations of $73,990 , and

What is Daniel Pichl's' Mailing Address?

  • Mailing address is C/o Springworks Therapeutics, Inc. 100 Washington Blvd. Stamford CT 06902 CT

Springworks Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Saqib Islam, J.D., 2020 $540,750 - - $6,788,860 $405,563 - $7,735,173
Saqib Islam, J.D., 2019 $480,115 - - $2,470,056 $334,750 - $3,284,921
Saqib Islam, J.D., 2018 $406,510 - $1,181,322 - $180,000 - $1,767,832
Francis I. Perier, Jr., M.B.A., 2020 $405,600 - - $1,566,660 $243,360 - $2,215,620
Francis I. Perier, Jr., M.B.A., 2019 $144,583 - - $2,150,821 $77,231 - $2,372,635
Badreddin Edris, Ph.D., 2020 $409,500 - - $2,088,880 $245,700 - $2,744,080
Badreddin Edris, Ph.D., 2019 $377,609 - - $222,126 $202,800 $107,895 $910,430
Badreddin Edris, Ph.D., 2018 $112,500 - $339,900 - $33,140 $37,735 $523,275
L. Mary Smith, Ph.D., 2020 $409,500 - - $1,566,660 $245,700 - $2,221,860
L. Mary Smith, Ph.D., 2019 $369,784 - - $180,051 $202,800 - $752,636
L. Mary Smith, Ph.D., 2018 $279,865 - $123,644 - $79,000 - $482,509
Herschel S. Weinstein, J.D. 2020 $348,333 - - $2,256,594 $194,180 - $2,799,107
Daniel Pichl, 2020 $145,833 - - $2,095,305 $73,990 - $2,315,128
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1773427/000110465921050515/tm2110663-2_def14a.htm

What are Springworks Therapeutics, Inc's Past Insider Trades?

Springworks Therapeutics, Inc's most recent insider trade came on March 20, 2023 by Jeffrey Schwartz who sold 1,750,000 units worth $49.88M . In the last 4 years, insiders at Springworks Therapeutics, Inc have sold an estimated value of $383.67M and bought an estimated value of $14.59M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Mary Smith, Chief Development Officer,  Saqib Islam, Chief Executive Officer,  and Jeffrey Schwartz, Director .

SpringWorks Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...